On January 20, 2026, Arturo Molina, Chief Medical Officer at Protagonist Therapeutics (NASDAQ: PTGX), divested 9,514 shares through a direct open-market transaction worth approximately $784,700. According to SEC Form 4 filings, the sale occurred at $82.48 per share, representing the largest single d